longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

MDT

MDT
88.6400.97%( +0.850 )

LongbridgeAI

Orchestra BioMed says investigational AVIM hypertension therapy features in HRX Live sessions

PUBT
Sep 16, 2026 at 12:31 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Orchestra BioMed will present its investigational AVIM hypertension therapy at two sessions during HRX Live 2026 in Atlanta, Sept. 18-20, 2026. A Medtronic collaboration roundtable on Sept. 19 will highlight AVIM for uncontrolled hypertension, while a second panel on Sept. 18 will feature AVIM in the context of pacing beyond bradycardia.

  • Orchestra BioMed will present AVIM Therapy in two sessions at HRX Live 2026 in Atlanta on Sept. 18-20, 2026. * A Medtronic collaboration roundtable is scheduled for Sept. 19, 2026, 9:40-10:25 a.m. ET, highlighting AVIM for uncontrolled hypertension. * A second panel on pacing beyond bradycardia is set for Sept. 18, 2026, 4:45-5:30 p.m. ET, featuring AVIM. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609160830PRIMZONEFULLFEED9827649) on September 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Login to unlock478characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Orchestra BioMed

Orchestra BioMed

USOBIO

0.00%

Medtronic

Medtronic

USMDT

+0.97%